The Effect of Palmitoylethanolamide (PEA) on Skeletal Muscle Hypertrophy, Strength, and Power in Response to Resistance Training in Healthy Active Adults: A Double-Blind Randomized Control Trial
Abstract Background Palmitoylethanolamide (PEA) has analgesic/anti-inflammatory properties that may be a suitable alternative to over-the-counter (OTC) non-steroidal analgesics/anti-inflammatories. While OTC pain medications can impair strength training adaptations, the mechanism of action of PEA is...
Saved in:
Main Authors: | Zoya Huschtscha (Author), Jessica Silver (Author), Michael Gerhardy (Author), Charles S. Urwin (Author), Nathan Kenney (Author), Viet Hung Le (Author), Jackson J. Fyfe (Author), Simon A. Feros (Author), Andrew C. Betik (Author), Christopher S. Shaw (Author), Luana C. Main (Author), Gavin Abbott (Author), Sze-Yen Tan (Author), Anthony May (Author), Craig M. Smith (Author), Vicky Kuriel (Author), Jackson Barnard (Author), D. Lee Hamilton (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer's Disease
by: Sarah Beggiato, et al.
Published: (2019) -
Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients
by: Annalisa Noce, et al.
Published: (2021) -
Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence
by: Damiana Scuteri, et al.
Published: (2022) -
Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case-Control Study
by: Maria Albanese, et al.
Published: (2022) -
Peas and Primroses
by: Lynne S. Wilcox, MD, MPH
Published: (2005)